Showing 1,523 results

Filters Content type: News, Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Pharmaceutical industry

Is Gilead Sciences Its Own Worst Enemy?

Editor's pick
Motley Fool
20 May 2015
Pharmaceutical industry

Glaxo drops plans to float 'gamechanging' HIV drugs arm, favouring in-house profits

Editor's pick
The Independent
7 May 2015
Pharmaceutical industry

Glaxo Abandons HIV-Unit Spinoff Plan, Reduces Capital Payout

Editor's pick
Bloomberg
6 May 2015
Treatment guidelines

US guidelines shift to integrase-based combinations for first-line treatment: Atripla relegated due to side effects

Editor's pick
i-Base
6 May 2015
Access to healthcare

Civil Society Groups Tell UNITAID: Support access mechanisms led by civil society, not the pharmaceutical industry

Editor's pick
Hep C Coalition
5 May 2015
Pharmaceutical industry

Gilead’s Gaffe Leads Drugmakers to Pledge More Openness on Price

Editor's pick
Bloomberg
5 May 2015
Hepatitis C treatment

Egypt opens first factory for locally produced Sovaldi

Editor's pick
News Egypt
5 May 2015
Pharmaceutical industry

Gilead first-quarter profit doubles on strong hepatitis C drug sales

Editor's pick
Reuters
5 May 2015
Hepatitis C treatment

Merck Faces Hep C Pricing Dilemma to Counter Gilead, Abbvie

Editor's pick
The Street
9 April 2015
Men who have sex with men (MSM)

ViiV Healthcare Launches New Global Positive Action Programme Focused on MSM and Transgender Populations

Editor's pick
Viiv Healthcare press release
31 March 2015
Hepatitis C treatment

Bristol-Myers Squibb Co. Is Back in the Hepatitis C Race

Editor's pick
Motley Fool
18 March 2015
The search for a cure

Beware Of Sangamo: 20-Year History Of Failures, Misadventures In HIV, And Flawed Approach In B-Thalassemia

Editor's pick
Seeking Alpha
10 March 2015
Hepatitis C treatment

Here Is Why Gilead Sciences, Inc. Is Still Doing Better Than AbbVie Inc

Editor's pick
Bidness
10 March 2015
Access to healthcare

$10 Copy of Gilead Blockbuster Sovaldi Appears in Bangladesh

Editor's pick
Bloomberg
9 March 2015
Access to healthcare

EECA CAB positions in regards to Janssen, BMS, Gilead and ViiV policy

Editor's pick
EATG
9 March 2015
Hepatitis C treatment

Natco Pharma ties up with Gilead on hepatitis C drugs

Editor's pick
Reuters
4 March 2015
PrEP

PrEP Access For HIV Prevention In Australia A Step Closer As Gilead Applies To TGA

Editor's pick
Star Observer
3 March 2015
Pharmaceutical industry

Gilead avoids billions in U.S. taxes on its $1,000-a-pill drug

Editor's pick
Chicago Tribune
27 February 2015
PrEP

HIV and LGTB NGOs and other concerned actors across Europe call for futher action on pre-exposure prophylaxis

Editor's pick
EATG
25 February 2015
Access to healthcare

Merck places children's HIV drug in shared non-profit patent pool

Editor's pick
Reuters
24 February 2015
Hepatitis C treatment

amfAR Report Examines Controversial Pricing of Hepatitis C Treatment

Editor's pick
amfAR
19 February 2015
Pharmaceutical industry

The Drug That Is Bankrupting America

Editor's pick
Huffington Post
18 February 2015
Pharmaceutical industry

Patient groups rank ViiV Healthcare #1 in corporate reputation survey, again

Editor's pick
Bio Pharma Dive
16 February 2015
Pharmaceutical industry

How ViiV Healthcare became a pharma favorite for patient groups

Editor's pick
BioPharma Dive
16 February 2015